Furthermore, it has been observed that mutations at positions 912, 914 or 915 (E. coli numbering) in chloroplast 16S rRNA confer resistance to streptomycin (23, 24) , and mutations at position 912 have been shown to lower the response of ribosomes to streptomycin when introduced into E. coli 16S rRNA (18, 19) .
INTRODUCTION
Recent work has demonstrated that specific regions of rRNA participate in the process of translation (reviewed in 1-3). Various antibiotics inhibit protein synthesis in bacteria by binding directly to rRNA (4,5, reviewed in 6) . One such compound is streptomycin, an aminoglycoside drug which perturbs control of translational accuracy (7, 8) , by essentially abolishing the proofreading step (9) (10) (11) . Streptomycin binds with high affinity to a single site on the 30S subunit off. coli ribosome (12, 13) , where it primarily interacts with 16S rRNA (14, 15) .
Cross-linking experiments have shown that streptomycin can be linked to a fragment of 16S rRNA spanning residues 892 to 917 (16) , and footprinting studies indicated that bases 909, 911, 912, and predominantly bases 913 to 915, are protected by streptomycin (4) . Several residues in this region are also protected by protein S12 (see Fig. 1 ), which, when altered, can produce a phenotype of streptomycin resistance (21) or dependence (22) .
MATERIALS AND METHODS

Bacterial strains and plasmids
Plasmid pKK3535, which contains the entire rmB operon (25) , was kindly provided by Dr Harry Noller, University of California, Santa Cruz. Plasmid pEM109, a derivative of pKK3535 with the C -U mutation at position 912 of the 16S rRNA (18) , was kindly given by Dr Rolf Wagner, HeinrichHeine-Universitat, Dusseldorf. Phagemid pDL4417, which was used for mutagenesis, is a derivative of Bluescript SK~(Stratagene) which contains the 16S rRNA gene of the E. coli rmB operon (26) .
The E. coli strain K12A19, RNase I~, was the source of initiation factors and enzymes for cell-free protein synthesis assays. Strains XLJ-Blue (Stratagene) and DHI (27) were used as hosts for plasmids derived from pDL4417 and from pKK3535, respectively. Strain Sm r -19 is a spontaneous streptomycinresistant mutant derived from DHI, with an altered protein S12. 
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The error frequency is the ratio of the amount of isoleucine to that of phenylalanine incorporated into hot trichloroacetic acid-insoluble material under the direction of poly(U). The amount of ribosomes was 0,5 A^o unit in 100 y\, and poly(U) was present at 40 pg/ml. l2 C]phenylalanine. Phenylalanine and isoleucine were at a concentration of 10 /iM and 1 /iM, respectively. Streptomycin was present at a molar ratio of 10 per ribosome. Blanks without ribosomes were subtracted. Results are the means of six independent experiments. The standard deviation on the means was less than or equal to 15%. Numbers between parentheses indicate the amount in pmol of phenylalanine and isoleucine incorporated. The incorporation of isoleucine in the absence of streptomycin was 20 000 ± 6000 cpm with wildtype ribosomes, 6000 ± 2000 cpm with streptomycin-resistant ribosomes with mutated S12, and 16000 ± 6000 cpm with the mixtures containing 67% mutant ribosomes with mutated S12 or 16S rRNA. The efficiency of counting was 18%. Figure 1 . Portion of Escherichia coli 16S rRNA which is involved in the response to streptomycin. This portion is from the secondary structure by Stern et al. (17) . Circled residues are protected by streptomycin (4) . Arrowheads point to sites where substitutions were introduced: full arrowheads (this work); open arrowhead (18, 19) . Symbols V and A refer to sites where the reactivity is reduced or enhanced, respectively, upon binding of protein S12 to 16S rRNA (20 (12) . Its specific activity was 3,3 Ci/mmol.
Construction of mutant plasmids
Mutagenesis in the 915 region of 16S rRNA was performed with the phosphorothioate method (28) on phagemid pDL4417 singlestranded DNA, using the Amersham in vitro oligonucleotidedirected mutagenesis system. After transformation of XLI-Blue cells, pseudophages were obtained by infection with the helperphage M13K07 (Pharmacia). Extracted single-stranded DNA was sequenced by the dideoxynucleotide chain termination method (29) .
The 800 bp BglH-BstEH fragments, which span the mutated region, were excised from the mutant phagemids and substituted for the corresponding fragment of pKK3535. The mutant derivatives of pKK3535 were isolated from transformed bacteria, analyzed by digestion with various restriction enzymes, and the presence of the mutation was confirmed by chemical sequencing (30) .
Quantitation of plasmid-encoded rRNA in the ribosome population
Ribosomes were isolated by standard procedures (15) from DHI cells transformed with pKK3535 or its mutant derivatives. Ribosomal RNA was isolated by phenol extraction from the ribosomes, and was used as a template for primer extension by AMV reverse transcriptase (Pharmacia), using the method described by Sigmund et al. (31) , with appropriately designed primers. The percentage of wild-type and mutant rRNA was assessed by determining relative band intensities of autoradiographs, with an LKB Ultroscan XL laser densitometer.
Protein synthesis assays Polypeptide synthesis was programmed with MS2 RNA, as described (26) , with or without streptomycin. MS2 RNA was obtained by a standard procedure (32) . The error frequency was assessed by measuring the ratio of isoleucine to phenylalanine incorporated under the direction of poly(U) in the presence of streptomycin (26): two parallel sets of assays were conducted, one in which phenylalanine was radiolabeled and the other, in which isoleucine was labeled. 
RESULTS
Construction and expression of 16S mutant rRNA
Single base mutations at positions 913, 914 and 915 in 16S rRNA were produced by oligonucleotide-directed mutagenesis and introduced into pKK3535. Only two of the nine mutations (913A-G and 915A -G) were tolerated in E. coli cells transformed with the mutant derivatives of pKK3535, which were coined pKK913G and pKK915G, respectively. These mutations did not alter the growth rate, and did not confer a detectable level of resistance to streptomycin in vivo (data not shown). The other seven mutations could not be retrieved in plasmids extracted from transformed bacteria, and the occurrence of huge deletions in these plasmids indicated that the mutated rrn operon was rearranged by the cells (see 34, 35) , implying that these mutations were not viable in E. coli.
We characterized the ribosomes isolated from strains harbouring the plasmids with the 913A-G or the 915A-G mutation. Ribosomes isolated from the strain containing the plasmid with the 912C -U mutation (18) were also included in this study, since this mutation was previously reported to reduce the response to streptomycin. However, in the previous study, bacteria transformed with the plasmid bearing the 912C-U mutation had been exposed to increasing concentrations of streptomycin, in order to raise the proportion of mutated ribosomes (18) . This procedure was avoided in this work, since it can lead to the appearance of mutations in ribosomal proteins (19, our unpublished results). The percentage of mutated ribosomes in bacteria transformed with the plasmids with the 912C-U, 913A-G or 915A -G mutation was about 67% as expected (see 36), and we decided to investigate the response to streptomycin of this mixed population. The response to an antibiotic of such mixed populations with a high percentage of mutant ribosomes has already been successfully investigated (37) .
Misreading assays
The effect of die mutations in 16S rRNA on the response of ribosomes to streptomycin was assessed by in vitro assays, since the dominance of streptomycin-sensitive ribosomes precludes the in vivo detection of an altered response to streptomycin (38 Ribosome preparations containing mutated 16S rRNA (912C-U, 913A -G and 915A-G) were examined for the stimulation of the incorporation of isoleucine directed by poly(U) in the presence of streptomycin (Table I ). For comparison, we also examined ribosomes with mutated protein S12, isolated from a spontaneous streptomycin-resistant strain, Sm r -19, and a mixture of these ribosomes with ribosomes from wild-type cells. Our results show that the 912C-U, 913A-G or 915A-G mutation in the 16S rRNA did not significantly affect the incorporation of the cognate amino acid phenylalanine, but restricted the stimulation of misreading by streptomycin. Ribosomes with the 912C -U or 915A -G mutation had a response which compares to that of an heterogeneous population containing 67% of streptomycinresistant ribosomes with mutated S12 and 33% of streptomycinsensitive wild-type ribosomes. The 913A-G mutation also restricted the response to streptomycin, albeit to a lesser extent. The mutations in the 915 region did not affect the stimulation of misreading by other error-promoting aminoglycoside antibiotics, such as neomycin, kanamycin or gentamicin (data not shown). Table II shows the effect of streptomycin on peptide synthesis with ribosomes under the direction of a natural messenger, MS2 RNA. The messenger RNA was added in excess over ribosomes. These conditions had been previously shown by Wallace and Davis (38) to avoid die blockage of initiation sites by sensitive ribosomes. This blockage accounts for the known dominance of streptomycin sensitivity over resistance in vivo. The activity of the ribosomes was reduced by the S12 and the 912C-U mutations, but not by the 913A -G and 915A -G mutations. When streptomycin was added, the mutations in rRNA reduced the inhibition by the drug. The 912C-U, 915A-G and the S12 mutations had a similar effect, whereas the 913A-G mutation was slightly less restrictive. Table HI compares the binding of [   3   H ]dihydrostreptomycin to the different mutant ribosomes. The binding of the drug was reduced to the same extent with mutant ribosomes harbouring the 912C-U, the 915A-G, and the S12 mutation. The 913A -G mutation also decreased drug binding, but to a lesser extent. The level of streptomycin binding correlated with the response of ribosomes to the drug.
Protein synthesis under the direction of a natural messenger
DISCUSSION
The results of this study demonstrate that mutations at positions 912, 913 or 915 of Escherichia coli 16S rRNA interfere with the binding of streptomycin. This interference directly correlates with a reduced stimulation of misreading and a decreased inhibition of protein synthesis by the drug. It can therefore be concluded that the 912-915 region controls the binding of streptomycin, in agreement with the footprinting studies of Moazed and Noller (4) . However, our results do not determine whether the 912-915 region directly interacts with streptomycin or is involved in a conformational rearrangement which stabilizes the binding of the drug, as suggested (39) . Allen and Noller (40) recently showed that there is an equilibrium between two conformational states of the 30S subunit, which differ in the reactivity of some residues proximal to the 915 region of 16S rRNA. Mutations in protein S12, which reduce streptomycin binding, shift the equilibrium towards one conformer whereas mutations in protein S4, which increase streptomycin binding (41) , favour the displacement towards the other conformer. Mutations in the 915 region of 16S rRNA could shift the equilibrium in the same direction as the S12 mutations, with the result that the mutant ribosomes bind less antibiotic.
A hierarchy was observed when comparing the effects of the mutations in the 915 region: the C -U mutation at position 912 and the A-G mutation at position 915 affected the binding of streptomycin as much as the mutation in protein S12, whereas the A-G mutation at position 913 affected the binding of the drug to a lesser extent. The other substitutions at positions 913-915 which were investigated in this study were lethal, which stresses the importance of this area for the function of the ribosome. Interestingly, Frattali et al. (19) observed that deletion of C912 is lethal, whereas the C -G mutation at position 912 causes retardation of cell growth. Consistent with these observations pointing to the importance of the 915 region, the compilation of rRNA sequences from a large range of organisms showed that residues 913 to 915 are highly conserved (42) . Howewer, the A -C substitution at position 914, which is lethal in E. coli, is viable in the chloroplasts of Chlamydomonas reinhardtii, where it confers streptomycin resistance (24) . Differences in protein-RNA interactions in this ribosomal area could account for this discrepancy. Other cases were reported where a mutation in rRNA is lethal in one species but viable in another one. For example, the C -G mutation at position 1409 of 16S rRNA is lethal in E. coli (43) and viable in yeast mitochondria (44) .
The 915 region of 16S rRNA is at the confluence of three major secondary structural domains (17, 45) . In the models describing the folding of 16S rRNA in the 30S subunit, this region is located between the decoding region, around position 1400 in the cleft of the 30S subunit, and the 530 loop, at the rear of the 30S subunit and proximal to protein S12 (17, 45, 46) . Since streptomycin selectively perturbs the proofreading step in the selection of tRNA (9 -11) , it is tempting to suggest that the 915 region, which controls the binding of this drug, could also be part of the site that controls the proofreading step. An alternative suggestion is that streptomycin perturbs translational accuracy by inducing ribosomal conformational changes, which are transmitted from its binding site to the site involved in the proofreading control. Other error-promoting drugs such as neomycin, kanamycin or gentamicin share with streptomycin the property of perturbing the proofreading control (47, 48) . Resistance to these drugs, which do not bind to the same site as streptomycin (4, 12, 49) , results from modifications or substitutions of 16S rRNA at positions 1405, 1408, 1409 or 1491 (43, 50) . If the 915 region was part of the site that controls the proofreading step, mutations in this region could alter the stimulation of misreading by these drugs. This was shown not to be the case. However, this result neither supports nor invalidates an involvement of the 915 region in the proofreading step, since those mutations in the 915 region which are viable could be without effect on the proofreading control. The second alternative proposes that streptomycin induces conformational changes in the proofreading control site, a region which would be distinct from its binding site. An attractive candidate for the proofreading control is the 530 loop region of 16S rRNA. Indeed, footprinting studies have indicated that the reactivity of this loop is allosterically affected upon binding of tRNA (51) , neomycin, kanamycin and gentamicin (4) . Although no effect could be observed with streptomycin alone, its presence increased the conformational changes induced in the 530 region upon binding of tRNA (Harry F.Noller, personal communication). Furthermore, mutations in this region were found to confer streptomycin resistance to the ribosome (24,52 -54) , or to suppress ochre nonsense mutations (55) . Experiments are in progress in our laboratory to further investigate the possible involvement of the 530 region in the proofreading control of translational accuracy.
